Skip to main content
Erschienen in: Diabetologia 11/2007

01.11.2007 | Article

Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis

verfasst von: A. E. Butler, R. Galasso, J. J. Meier, R. Basu, R. A. Rizza, P. C. Butler

Erschienen in: Diabetologia | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Type 1 diabetes is characterised by a deficit in beta cell mass thought to be due to immune-mediated increased beta cell apoptosis. Beta cell turnover has not been examined in the context of new-onset type 1 diabetes with diabetic ketoacidosis.

Methods

Samples of pancreas were obtained at autopsy from nine patients, aged 12 to 38 years (mean 24.3±3.4 years), who had had type 1 diabetes for less than 3 years before death due to diabetic ketoacidosis. Samples of pancreas obtained at autopsy from nine non-diabetic cases aged 11.5 to 38 years (mean 24.2±3.4 years) were used as control. Fractional beta cell area (insulin staining), beta cell replication (insulin and Ki67 staining) and beta cell apoptosis (insulin and TUNEL staining) were measured.

Results

In pancreas obtained at autopsy from recent-onset type 1 diabetes patients who had died of diabetic ketoacidosis, the beta cell deficit varied from 70 to 99% (mean 90%). The pattern of beta cell loss was lobular, with almost all beta cells absent in most pancreatic lobules; islets in lobules not devoid of beta cells had reduced or a near-normal complement of beta cells. Beta cell apoptosis was increased in recent-onset type 1 diabetes, but to a surprisingly modest degree given the marked hyperglycaemia (30 mmol/l), acidosis and presumably high NEFA. Beta cell replication, scattered pancreatic beta cells and beta cells in exocrine ducts were not increased in recent-onset type 1 diabetes.

Conclusions/interpretation

These findings do not support the notion of active beta cell regeneration by replication in new-onset type 1 diabetes under conditions of diabetic ketoacidosis. The gluco-lipotoxicity reported in isolated human islets may be less evident in vivo.
Literatur
1.
Zurück zum Zitat Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221–229CrossRef Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221–229CrossRef
2.
Zurück zum Zitat Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633CrossRef Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633CrossRef
3.
Zurück zum Zitat Junker K, Egeberg J, Kromann H et al (1977) An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand A 85:699–706 Junker K, Egeberg J, Kromann H et al (1977) An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand A 85:699–706
4.
Zurück zum Zitat Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251–261CrossRef Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251–261CrossRef
5.
Zurück zum Zitat Kloppel G, Drenck CR, Oberholzer M et al (1984) Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch A Pathol Anat Histopathol 403:441–452CrossRef Kloppel G, Drenck CR, Oberholzer M et al (1984) Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch A Pathol Anat Histopathol 403:441–452CrossRef
6.
Zurück zum Zitat Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456–461CrossRef Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456–461CrossRef
7.
Zurück zum Zitat Lernmark A, Kloppel G, Stenger D et al (1995) Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch 425:631–640CrossRef Lernmark A, Kloppel G, Stenger D et al (1995) Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch 425:631–640CrossRef
8.
Zurück zum Zitat Lohr M, Kloppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762CrossRef Lohr M, Kloppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762CrossRef
9.
Zurück zum Zitat Meier JJ, Bhushan A, Butler AE et al (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221–2228CrossRef Meier JJ, Bhushan A, Butler AE et al (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221–2228CrossRef
10.
Zurück zum Zitat Meier JJ, Lin JC, Butler AE et al (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844CrossRef Meier JJ, Lin JC, Butler AE et al (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844CrossRef
11.
Zurück zum Zitat Allen FM (1922) Hydropic degeneration of islands of Langerhans after partial pancretectomy. J Metab Res 1:5–41 Allen FM (1922) Hydropic degeneration of islands of Langerhans after partial pancretectomy. J Metab Res 1:5–41
13.
Zurück zum Zitat Palmer JP, Fleming GA, Greenbaum CJ et al (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21–22 October 2001. Diabetes 53:250–264CrossRef Palmer JP, Fleming GA, Greenbaum CJ et al (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21–22 October 2001. Diabetes 53:250–264CrossRef
14.
Zurück zum Zitat Tsai EB, Sherry NA, Palmer JP et al (2006) The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia 49:261–270CrossRef Tsai EB, Sherry NA, Palmer JP et al (2006) The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia 49:261–270CrossRef
15.
Zurück zum Zitat Hramiak IM, Dupre J, Finegood DT (1993) Determinants of clinical remission in recent-onset IDDM. Diabetes Care 16:125–132CrossRef Hramiak IM, Dupre J, Finegood DT (1993) Determinants of clinical remission in recent-onset IDDM. Diabetes Care 16:125–132CrossRef
16.
Zurück zum Zitat Karges B, Durinovic-Bello I, Heinze E et al (2004) Complete long-term recovery of beta-cell function in autoimmune type 1 diabetes after insulin treatment. Diabetes Care 27:1207–1208CrossRef Karges B, Durinovic-Bello I, Heinze E et al (2004) Complete long-term recovery of beta-cell function in autoimmune type 1 diabetes after insulin treatment. Diabetes Care 27:1207–1208CrossRef
17.
Zurück zum Zitat Rasouli N, Elbein SC (2004) Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab 89:6331–6335CrossRef Rasouli N, Elbein SC (2004) Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab 89:6331–6335CrossRef
18.
Zurück zum Zitat Kumar D, Luna-Lollie T, Madha S (2001) One-hour meal tolerance test to assess withdrawal of insulin therapy in overweight patients with type 2 diabetes. Endocr Pract 7:256–261CrossRef Kumar D, Luna-Lollie T, Madha S (2001) One-hour meal tolerance test to assess withdrawal of insulin therapy in overweight patients with type 2 diabetes. Endocr Pract 7:256–261CrossRef
19.
Zurück zum Zitat Matveyenko AV, Veldhuis JD, Butler PC (2006) Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes 55:2347–2356CrossRef Matveyenko AV, Veldhuis JD, Butler PC (2006) Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes 55:2347–2356CrossRef
20.
Zurück zum Zitat Ritzel RA, Butler AE, Rizza RA et al (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29:717–718CrossRef Ritzel RA, Butler AE, Rizza RA et al (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29:717–718CrossRef
21.
Zurück zum Zitat Federici M, Hribal M, Perego L et al (2001) High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50:1290–1301CrossRef Federici M, Hribal M, Perego L et al (2001) High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50:1290–1301CrossRef
22.
Zurück zum Zitat Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860CrossRef Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860CrossRef
23.
Zurück zum Zitat Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442CrossRef Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442CrossRef
24.
Zurück zum Zitat Meier JJ, Butler AE, Galasso R et al (2006) Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans. Diabetologia 49:2689–2696CrossRef Meier JJ, Butler AE, Galasso R et al (2006) Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans. Diabetologia 49:2689–2696CrossRef
25.
Zurück zum Zitat Stenstrom G, Gottsater A, Bakhtadze E et al (2005) Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 54(Suppl 2):S68–S72CrossRef Stenstrom G, Gottsater A, Bakhtadze E et al (2005) Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 54(Suppl 2):S68–S72CrossRef
26.
Zurück zum Zitat Robertson RP, Harmon JS (2006) Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 41:177–184CrossRef Robertson RP, Harmon JS (2006) Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 41:177–184CrossRef
27.
Zurück zum Zitat Kahl CR, Means AR (2003) Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24:719–736CrossRef Kahl CR, Means AR (2003) Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24:719–736CrossRef
28.
Zurück zum Zitat Donath MY, Ehses JA, Maedler K et al (2005) Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108–S113CrossRef Donath MY, Ehses JA, Maedler K et al (2005) Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108–S113CrossRef
Metadaten
Titel
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis
verfasst von
A. E. Butler
R. Galasso
J. J. Meier
R. Basu
R. A. Rizza
P. C. Butler
Publikationsdatum
01.11.2007
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 11/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0794-x

Weitere Artikel der Ausgabe 11/2007

Diabetologia 11/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.